TBCA (0-100 μM; 24 hours) shows a drastic effect on Jurkat cells viability.
TBCA also inhibits CK2 double mutant (Val66 Ile174) with an IC50 of 0.68 μM.
TBCA dose-dependently inhibits platelet aggregation and secretion induced by various agonists including 2-MeSADP, AYPGKF, SFLLRN, and CRP. TBCA also inhibits phosphorylation of PDK1, Akt, and GSK3β induced by AYPGKF.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line: |
Jurkat cells |
Concentration: |
0-100 μM |
Incubation Time: |
24 hours |
Result: |
The viability of Jurkat cells was reduced.
|